Product Information

MY WAY 1.5 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $6.3667 per EA under NDC 68180085211. Its NADAC has been published 484 times since May 17, 2017.

FDA first approved this application on Jun 19, 2014.

The High Outlier badge above means this manufacturer's average price in the levonorgestrel market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MY WAY 1.5 MG TABLET

levonorgestrel
$6.3667per EA
High Outlier
OTC

Strength

1.5 mg/1

NDC

68180085211

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVONORGESTREL

Approval Type

Generic (ANDA)

FDA Application

ANDA201446

FDA Approved

6/19/2014

On Market Since

4/25/2017

Pharmacological Classes

Inhibit Ovum Fertilization
Progesterone Congeners
Progesterone Congeners
Progestin
Progestin-containing Intrauterine System

Price Statistics

The NADAC for MY WAY 1.5 MG TABLET has been published 484 times since May 17, 2017, and over the history we have for it it has declined 69.6%. The table below summarizes its recorded NADAC range and movement.

Current price$6.3667 per EA
All-time high$20.9571 (Nov 15, 2017)
All-time low$5.2568 (Nov 20, 2024)
52-week high$6.8109
52-week low$6.2162
Median price$9.2819
Average price$10.0300
Largest weekly change+32.8% (Jun 20, 2018)
Weeks tracked484
Tracking sinceMay 17, 2017

Price History

1W

+0.8%

1M

+0.8%

3M

-0.7%

6M

-3.5%

1Y

-1.9%

3Y

-6.8%

5Y

-34.2%

All

-69.6%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of MY WAY 1.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MY WAY 1.5 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $6.3667 per EA (NDC 68180085211), effective Aug 19, 2026.

How has the price of MY WAY 1.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for MY WAY 1.5 MG TABLET has declined 69.6%. It has been tracked across 484 weekly CMS publications since May 17, 2017.

What are the highest and lowest recorded NADAC prices for MY WAY 1.5 MG TABLET?

Since May 17, 2017, the NADAC for MY WAY 1.5 MG TABLET has ranged from a low of $5.2568 (Nov 20, 2024) to a high of $20.9571 (Nov 15, 2017), with a median of $9.2819 per EA.

Are there cheaper alternatives to MY WAY 1.5 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MY WAY 1.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MY WAY 1.5 MG TABLET?

MY WAY 1.5 MG TABLET (NDC 68180085211) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.